Decreased protamine-1 transcript levels in testes from infertile men

Klaus Steger1, Ludger Fink, Klaus Failing

  • 1Institute of Veterinary Anatomy, Histology and Embryology, University of Giessen, Germany. Klaus.Steger@vetmed.uni-giessen.de

Insights

Male infertility is linked to a lower amount of protamine-1 (Prm1) mRNA, disrupting the Prm1 to protamine-2 (Prm2) ratio. This finding may help predict intracytoplasmic sperm injection (ICSI) success.

Area of Science:

  • Reproductive Biology
  • Molecular Genetics
  • Andrology

Background:

  • Infertile men often display an abnormal protamine-1 (Prm1) to protamine-2 (Prm2) ratio at both mRNA and protein levels.
  • This aberrant ratio is a potential indicator of impaired male fertility.

Purpose of the Study:

  • To investigate the relationship between the quantity of Prm1 and Prm2 mRNA and male infertility.
  • To determine if Prm1 and Prm2 mRNA levels can predict the success of intracytoplasmic sperm injection (ICSI).

Main Methods:

  • Real-time quantitative PCR was used to measure Prm1 and Prm2 mRNA levels.
  • RNA was extracted from routinely Bouin-fixed and paraffin-embedded testicular biopsies (n=51).
  • Samples were normalized for tissue section size and quantity.

Main Results:

  • The amount of Prm1 mRNA was significantly lower in men with impaired spermatogenesis compared to those with obstructive azoospermia and normal spermatogenesis.
  • A significantly decreased Prm1 to Prm2 mRNA threshold cycle difference (deltaC(T)) was observed in infertile groups.
  • A negative correlation was found between spermatogenesis efficiency score and Prm1 mRNA levels.

Conclusions:

  • A decreasing amount of Prm1 mRNA and the resulting aberrant Prm1:Prm2 ratio are significant factors in male infertility.
  • Prm1 mRNA levels may serve as a predictive biomarker for ICSI outcomes in infertile men.

Related Concept Videos

Infertility in Males01:23

Infertility in Males

Male infertility affects millions of couples worldwide, arising from various factors that impact different stages of the reproductive process. An endocrine imbalance resulting from conditions like hypogonadism, Klinefelter syndrome, or pituitary disorders can disrupt hormone levels and reduce sperm production. Testicular defects, such as tumors, cryptorchidism, atrophic testes, abnormal sperm morphology, and low sperm count or motility, may arise due to genetic factors, structural...
Spermatogenesis01:41

Spermatogenesis

Spermatogenesis is the process by which haploid sperm cells are produced in the male testes. It starts with stem cells located close to the outer rim of seminiferous tubules. These spermatogonial stem cells divide asymmetrically to give rise to additional stem cells (meaning that these structures “self-renew”), as well as sperm progenitors, called spermatocytes. Importantly, this method of asymmetric mitotic division maintains a population of spermatogonial stem cells in the male reproductive...
Menopause01:28

Menopause

Menopause, a natural biological process marking the end of a woman's fertility, typically occurs between the fifth and sixth decade of life. This phase is characterized by the exhaustion of the ovarian follicle pool, leading to less responsive ovaries despite the high levels of Follicle Stimulating Hormone (FSH) and Luteinizing Hormone (LH). The consequential decrease in estrogen production results in symptoms like hot flashes, heavy sweating, headaches, hair loss, muscle pains, vaginal...